Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
DESIGN CONTROL INSPECTION SCOPE TO BE CLARIFIED BY FDA IN UPCOMING POLICY STATEMENT; FIRMS WILL CHOOSE WHICH PRODUCTS UNDERGO DESIGN CONTROL AUDITS
Jun 16 1997
More from Archive
More from Medtech Insight